172 related articles for article (PubMed ID: 30260027)
1. Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ.
Frazão JB; Colombo M; Simillion C; Bilican A; Keller I; Wüthrich D; Zhu Z; Okoniewski MJ; Bruggmann R; Condino-Neto A; Newburger PE
J Cell Biochem; 2019 Mar; 120(3):4321-4332. PubMed ID: 30260027
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
Condino-Neto A; Newburger PE
Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
Ezekowitz RA; Orkin SH; Newburger PE
J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
Ahlin A; Elinder G; Palmblad J
Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
6. Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferon-treated human cells.
Turpaev KT; Zakhariev VM; Sokolova IV; Narovlyansky AN; Amchenkova AM; Justesen J; Frolova LY
Eur J Biochem; 1996 Sep; 240(3):732-7. PubMed ID: 8856077
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
8. Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous disease.
Cobbs CS; Malech HL; Leto TL; Freeman SM; Blaese RM; Gallin JI; Lomax KJ
Blood; 1992 Apr; 79(7):1829-35. PubMed ID: 1313715
[TBL] [Abstract][Full Text] [Related]
9. Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene.
Goldberg M; Belkowski LS; Bloom BR
J Clin Invest; 1990 Feb; 85(2):563-9. PubMed ID: 2153711
[TBL] [Abstract][Full Text] [Related]
10. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines.
Fleckner J; Martensen PM; Tolstrup AB; Kjeldgaard NO; Justesen J
Cytokine; 1995 Jan; 7(1):70-7. PubMed ID: 7749068
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
Jackson SH; Miller GF; Segal BH; Mardiney M; Domachowske JB; Gallin JI; Holland SM
J Interferon Cytokine Res; 2001 Aug; 21(8):567-73. PubMed ID: 11559434
[TBL] [Abstract][Full Text] [Related]
13. Chinese patients with defective IL-12/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele.
Lee WI; Huang JL; Lin TY; Hsueh C; Wong AM; Hsieh MY; Chiu CH; Jaing TH
J Clin Immunol; 2009 Mar; 29(2):238-45. PubMed ID: 18972195
[TBL] [Abstract][Full Text] [Related]
14. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
[TBL] [Abstract][Full Text] [Related]
15. The use of interferon-gamma therapy in chronic granulomatous disease.
Errante PR; Frazão JB; Condino-Neto A
Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):225-30. PubMed ID: 18991804
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the interferon-gamma-inducible tryptophanyl-tRNA synthetase includes alternative splicing.
Tolstrup AB; Bejder A; Fleckner J; Justesen J
J Biol Chem; 1995 Jan; 270(1):397-403. PubMed ID: 7814400
[TBL] [Abstract][Full Text] [Related]
17. Drug-selected complete restoration of superoxide generation in Epstein-Barr virus-transformed B cells from p47phox-deficient chronic granulomatous disease patients by using a bicistronic retrovirus vector encoding a human multi-drug resistance gene (MDR1) and the p47phox gene.
Iwata M; Nunoi H; Matsuda I; Kanegasaki S; Tsuruo T; Sugimoto Y
Hum Genet; 1998 Oct; 103(4):419-23. PubMed ID: 9856484
[TBL] [Abstract][Full Text] [Related]
18. In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype.
Ambruso DR; Briones NJ; Baroffio AF; Murphy JR; Tran AD; Gowan K; Sanford B; Ellison M; Jones KL
PLoS One; 2022; 17(2):e0263370. PubMed ID: 35113934
[TBL] [Abstract][Full Text] [Related]
19. High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease.
Meda Spaccamela V; Valencia RG; Pastukhov O; Duppenthaler A; Dettmer MS; Erb J; Steiner UC; Hillinger S; Speckmann C; Ehl S; Reichenbach J; Siler U
Front Immunol; 2019; 10():2236. PubMed ID: 31681257
[No Abstract] [Full Text] [Related]
20. Effect of interferon-gamma, in vitro and in vivo, on mRNA levels of phagocyte oxidase components.
Weening RS; de Klein A; de Boer M; Roos D
J Leukoc Biol; 1996 Dec; 60(6):716-20. PubMed ID: 8975873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
